Amferia participated in a discussion with Brad from BiotechTV about the potential for Orexo.
Public source
Publisher name
Public post
Good discussion with Brad from BiotechTV about the potential for Orexo.
Company
Amferia
Amferia kills bacteria, even resistant bacteria, without harming the body
- Industry
- Medical Equipment Manufacturing
- Location
- Mölndal, SE
- Company size
- 11–50 employees
About Amferia
Amferia AB is a Swedish company that develops and markets new medical devices with emphasis on antibacterial products. The core focus of Amferia is to develop materials that can efficiently kill bacteria when used as medical devices, for example within wound care. Amferia is a spin-off from research performed at Chalmers University of Technology. The company was founded in 2018 and the founders of Amferia are Dr. Anand Kumar Rajasekharan, Professor Martin Andersson and Dr. Saba Atefyekta.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
electroCore, Inc.
electroCore, Inc. was featured on BioTuesdays
Presence & Recognition
PILA PHARMA
PILA PHARMA hosted a live review of H1 and commented on regulatory approval for a new longer clinical trial to explore higher doses with Infront Direkt Studios
Presence & Recognition
BiotechTV
BiotechTV covered Pareto Securities' 17th Annual Healthcare Conference, highlighting innovation coming out of the Nordics region and AI impact on biotech.
Presence & Recognition
Circio Holding ASA
Circio Holding ASA hosted a visit by the BiotechTV team in Stockholm to discuss circVec, circular RNA, and gene and cell therapy work.
Presence & Recognition
Optheras A/S